Major players in the hepatorenal syndrome treatment market are Becton, Dickinson and Company, BioVie Inc., Cumberland Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Orphan Therapeutics LLC ...

Hepatorenal Syndrome pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as .

Around 3+ key companies are developing therapies for Hepatorenal Syndrome. Noorik Biopharmaceuticals has its Hepatorenal Syndrome drug candidates in the mid to advanced stage (Phase II). An ...

Hospitalizations for hepatorenal syndrome with alcohol-related liver disease increased from 52.8% in 2018 to 59.8% in 2021, then decreased to 56.5% in 2023.

ALBANY, N.Y., Feb. 17, 2021 /PRNewswire/ -- The rising awareness of hepatorenal syndrome diseases among a considerable chunk of the populace and the escalating cases of cirrhosis are expected to ...

AUSTIN, Texas -- Hepatorenal syndrome (HRS) type 1 patients showed clinically meaningful responses to terlipressin (Terlivaz) under an alternative definition of treatment success, ...

In addition to 'Hepatorenal syndrome', there may be other similar symptoms or signs that better match your side effect. These have also been listed below for your convenience.

The FDA approved terlipressin (Terlivaz), the first drug for treating patients with hepatorenal syndrome (HRS).. A synthetic vasopressin analog, terlipressin is an injectable drug indicated for ...

DUBLIN, Nov. 12, 2021 /PRNewswire/ -- Mallinckrodt plc, (OTCMKTS: MNKKQ) a global biopharmaceutical company, today announced findings from two ret ...

In addition to hepatorenal syndrome and AKI, Schira touched on the role of acetaminophen in AKI. Here, she contended that while nephrotoxicity from the medication resulting in AKI is uncommon, ...

Hepatorenal syndrome usually signals an urgent state of liver disease. Monitoring kidney function through regular tests can help catch early warning signs and begin treatments sooner.